High MCM2 expression has been correlated with high-risk HPV and p16/CDKN2A expression in cervical cancer samples (Santin et al., 2005; Akagi et al., 2014; Zheng, 2015; Liao et al., 2018). The gene discussed is CDKN2A; the disease is cervical carcinoma.